McKesson Co. (NYSE:MCK) is Oak Thistle LLC’s 6th Largest Position

Oak Thistle LLC boosted its position in McKesson Co. (NYSE:MCK) by 3.7% during the 4th quarter, HoldingsChannel reports. The firm owned 5,117 shares of the company’s stock after purchasing an additional 184 shares during the period. McKesson comprises about 0.9% of Oak Thistle LLC’s investment portfolio, making the stock its 6th biggest position. Oak Thistle LLC’s holdings in McKesson were worth $2,916,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Oppenheimer & Co. Inc. increased its stake in shares of McKesson by 6.3% in the 2nd quarter. Oppenheimer & Co. Inc. now owns 3,905 shares of the company’s stock worth $2,281,000 after purchasing an additional 233 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in McKesson by 140.3% during the second quarter. Oppenheimer Asset Management Inc. now owns 2,992 shares of the company’s stock valued at $1,747,000 after purchasing an additional 1,747 shares during the period. Brown Brothers Harriman & Co. grew its holdings in McKesson by 5.9% during the second quarter. Brown Brothers Harriman & Co. now owns 1,902 shares of the company’s stock valued at $1,111,000 after purchasing an additional 106 shares during the period. Dimensional Fund Advisors LP increased its position in McKesson by 5.8% in the second quarter. Dimensional Fund Advisors LP now owns 395,150 shares of the company’s stock worth $230,821,000 after buying an additional 21,832 shares in the last quarter. Finally, One Capital Management LLC bought a new position in shares of McKesson in the second quarter worth about $1,055,000. 85.07% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on MCK shares. Mizuho initiated coverage on McKesson in a research note on Wednesday, December 4th. They set a “neutral” rating and a $630.00 price objective for the company. Robert W. Baird upgraded shares of McKesson from a “neutral” rating to an “outperform” rating and upped their price target for the stock from $531.00 to $688.00 in a research report on Thursday, November 7th. Evercore ISI lifted their target price on shares of McKesson from $560.00 to $680.00 and gave the company an “outperform” rating in a research note on Thursday, November 7th. Leerink Partners dropped their target price on shares of McKesson from $665.00 to $630.00 and set an “outperform” rating for the company in a report on Monday, October 7th. Finally, Bank of America decreased their price target on McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $646.14.

McKesson Trading Up 1.5 %

Shares of McKesson stock opened at $594.11 on Wednesday. McKesson Co. has a 12 month low of $464.42 and a 12 month high of $637.51. The stock has a 50 day moving average of $595.09 and a 200 day moving average of $560.90. The firm has a market cap of $75.42 billion, a PE ratio of 30.77, a PEG ratio of 1.25 and a beta of 0.52.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, November 6th. The company reported $7.07 EPS for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The firm had revenue of $93.65 billion during the quarter, compared to the consensus estimate of $89.33 billion. During the same period in the prior year, the company earned $6.23 EPS. The company’s quarterly revenue was up 21.3% compared to the same quarter last year. As a group, equities research analysts forecast that McKesson Co. will post 32.73 earnings per share for the current fiscal year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd were issued a $0.71 dividend. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.48%. McKesson’s dividend payout ratio (DPR) is presently 14.71%.

Insider Activity

In other McKesson news, EVP Leann B. Smith sold 579 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $602.81, for a total transaction of $349,026.99. Following the sale, the executive vice president now directly owns 1,443 shares of the company’s stock, valued at $869,854.83. The trade was a 28.64 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.11% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.